Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this ...

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the ...

Researchers have identified a compound produced by a variety of land snail that prevents blood clots without prolonging ...

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may ...

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

It was in the 1920s when a New Jersey pathologist first described what he called “punch-drunk syndrome,” a cluster of tremors, slowed movement, and speech difficulties seen in career boxers. Rebranded ...

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Pierre de Brémond d’Ars, a French GP who leads the evidence-based medicine group NoFakeMed, tells Medscape’s French edition ...

NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or ...